CN101010589A - 阿尔茨海默病的生物标记 - Google Patents

阿尔茨海默病的生物标记 Download PDF

Info

Publication number
CN101010589A
CN101010589A CNA2005800225150A CN200580022515A CN101010589A CN 101010589 A CN101010589 A CN 101010589A CN A2005800225150 A CNA2005800225150 A CN A2005800225150A CN 200580022515 A CN200580022515 A CN 200580022515A CN 101010589 A CN101010589 A CN 101010589A
Authority
CN
China
Prior art keywords
gsk
antibody
disease
alzheimer
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800225150A
Other languages
English (en)
Chinese (zh)
Inventor
S·洛夫斯通
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kings College London
Original Assignee
Kings College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kings College London filed Critical Kings College London
Publication of CN101010589A publication Critical patent/CN101010589A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CNA2005800225150A 2004-07-02 2005-07-01 阿尔茨海默病的生物标记 Pending CN101010589A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0414894.6 2004-07-02
GBGB0414894.6A GB0414894D0 (en) 2004-07-02 2004-07-02 Biomarkers of alzheimer's disease

Publications (1)

Publication Number Publication Date
CN101010589A true CN101010589A (zh) 2007-08-01

Family

ID=32843494

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800225150A Pending CN101010589A (zh) 2004-07-02 2005-07-01 阿尔茨海默病的生物标记

Country Status (9)

Country Link
US (1) US20080076140A1 (enExample)
EP (1) EP1763674A2 (enExample)
JP (1) JP2008504551A (enExample)
CN (1) CN101010589A (enExample)
AU (1) AU2005258926A1 (enExample)
BR (1) BRPI0512948A (enExample)
CA (1) CA2571692A1 (enExample)
GB (1) GB0414894D0 (enExample)
WO (1) WO2006003414A2 (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103180455A (zh) * 2010-07-22 2013-06-26 杨孝德 侦测致死系统的方法
CN104237526A (zh) * 2013-06-18 2014-12-24 磁量生技股份有限公司 一种检测阿兹海默症罹患风险的系统
CN104698188A (zh) * 2015-03-04 2015-06-10 华中科技大学 检测人血小板GSK-3β蛋白活性的斑点印迹方法
CN101899493B (zh) * 2008-12-17 2017-04-12 国立清华大学 不健康细胞的侦测方法及其应用
CN111323597A (zh) * 2018-12-14 2020-06-23 陈志成 用于检测受试者中mci和/或ad的方法、试剂盒及筛选化合物的方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007138408A1 (en) 2006-05-25 2007-12-06 Ge Healthcare Limited 11c/18 f-labeled inhibitors of glycogen synthase kinase-3
WO2009074331A2 (en) * 2007-12-11 2009-06-18 Julius-Maximilians-Universität Würzburg Early and differential diagnosis test for alzheimer's disease
EP2279420B1 (en) 2008-03-21 2014-01-29 Manuela G. Neuman METHODS FOR THE DIFFERENTIAL DIAGNOSIS OF ALZHEIMER'S DISEASE VERSUS FRONTOTEMPORAL DEMENTIA, COMPRISING FAS-L, TNF-alpha AND ccCK-18 AS BIOMARKERS
US20170102398A1 (en) * 2014-03-05 2017-04-13 Humanetics Corporation Predicting and reducing cognitive decline based on gsk-3 levels

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005240669A1 (en) * 2004-05-07 2005-11-17 Garvan Institute Of Medical Research Detecting disease association with aberrant glycogen synthase kinase 3-beta expression

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101899493B (zh) * 2008-12-17 2017-04-12 国立清华大学 不健康细胞的侦测方法及其应用
CN103180455A (zh) * 2010-07-22 2013-06-26 杨孝德 侦测致死系统的方法
CN104237526A (zh) * 2013-06-18 2014-12-24 磁量生技股份有限公司 一种检测阿兹海默症罹患风险的系统
CN104237526B (zh) * 2013-06-18 2016-08-17 磁量生技股份有限公司 一种检测阿兹海默症罹患风险的系统
CN104698188A (zh) * 2015-03-04 2015-06-10 华中科技大学 检测人血小板GSK-3β蛋白活性的斑点印迹方法
CN111323597A (zh) * 2018-12-14 2020-06-23 陈志成 用于检测受试者中mci和/或ad的方法、试剂盒及筛选化合物的方法

Also Published As

Publication number Publication date
WO2006003414A3 (en) 2006-03-16
BRPI0512948A (pt) 2008-04-15
JP2008504551A (ja) 2008-02-14
AU2005258926A1 (en) 2006-01-12
CA2571692A1 (en) 2006-01-12
GB0414894D0 (en) 2004-08-04
US20080076140A1 (en) 2008-03-27
WO2006003414A2 (en) 2006-01-12
EP1763674A2 (en) 2007-03-21

Similar Documents

Publication Publication Date Title
US20170176460A1 (en) Neural specific s100-beta for biomarker assays and devices for detection of a neurological condition
Joishy et al. Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease
Kiđemet‐Piskač et al. Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia
PT1856531E (pt) Processo para diagnosticar esclerose múltipla
EP2841945A1 (en) Methods and compositions for diagnosis and prognosis of stroke or other cerebral injury
CN102933966A (zh) 阿尔茨海默病的新型诊断制剂
CN107621545B (zh) Bicc1蛋白对精神疾病诊断的新用途
JP2016520827A (ja) 移植拒絶反応、神経変性疾患又はうつ病と特に関連する潜在的炎症のインビトロ早期検出方法
CN101010589A (zh) 阿尔茨海默病的生物标记
CN110726846B (zh) Hbp蛋白作为川崎病的诊断标志物的应用
US20160161499A1 (en) Sensitive diagnostic assay for inclusion body mysitis
CN110853719A (zh) 神经酰胺三己糖苷d18:0/24:1作为生物标志物在诊断阿尔茨海默病中的应用
Yang et al. The value of gene Xpert MTB/RIF, ADA, TB-DNA in the early diagnosis of TB meningitis
Nassef et al. Serum Endocan Levels and Subclinical Atherosclerosis in Behçet’s Syndrome
JP2025016807A (ja) 脳内アミロイドβの蓄積を評価するためのバイオマーカー
WO2024213092A1 (en) Protein markers for mild cognitive impairment and alzheimer's disease
CN119291173B (zh) 一种标志物用途及用于诊断神经精神性狼疮的磁微粒化学发光试剂盒
JP6436777B2 (ja) 精神関連疾患の検査方法および検査キット
CN113373214B (zh) Cd30在诊断脑神经相关疾病中的用途
CN113151443B (zh) 细胞因子联合分析作为精神分裂症标志物及其应用
US11609236B2 (en) Blood biomarkers for severe traumatic brain injuries
KR102145438B1 (ko) 퇴행성 뇌질환 발병 위험성 예측용 조성물 및 이를 이용한 퇴행성 뇌질환의 발병 위험성 예측 방법
Jing et al. Serum Neurofilament Light Chain and Inflammatory Cytokines as Biomarkers for Early Detection of Alzheimer's Disease
US20230273220A1 (en) Methods for prediction, detection and monitoring of substanceuse disorders and/or an infection
Altun et al. Lower Serum Kindlin-2 Levels are Associated with Liver Cirrhosis: A Preliminary Study

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20070801